Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/17/1994 | EP0298990B1 Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
11/17/1994 | DE4345177A1 Molsidomine pharmaceutical compositions |
11/17/1994 | DE4326948C1 Use of natural oestrogens for slowing down the aging process in men |
11/17/1994 | DE4316293A1 Use of a combination of anserine/carnosine and hypotaurine/taurine for controlling inflammatory disorders |
11/17/1994 | DE4315525A1 Pharmaceutical composition |
11/16/1994 | CN1095071A Compounds |
11/16/1994 | CN1095070A Novel process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives |
11/16/1994 | CN1095069A Novel process |
11/16/1994 | CN1095068A Bicyclic amine derivatives |
11/16/1994 | CN1095064A 1,4-benzoxazino derivatives |
11/16/1994 | CN1095062A Preparation of pure enantiomorisomer |
11/16/1994 | CN1095061A Use of disulfonyl methane for the control of parasties |
11/16/1994 | CN1094972A Release-controlled skin-penetrating therapeutic system and its preparation and application |
11/16/1994 | CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
11/16/1994 | CN1094958A Shenshixiao capsule for eliminating kidney stone |
11/16/1994 | CN1094951A Long-acting kangliling antidysenteric suspended injection for animals and preparation method thereof |
11/16/1994 | CN1094950A Compositions of L-dopa esters |
11/16/1994 | CN1094949A Viaminate high-efficiency preparation |
11/16/1994 | CN1094948A Controlled release device |
11/16/1994 | CN1026589C N-substituted derivatives of 3R, 4R-ethyl-(1-methyl-1H-imidzaol-5-yl)methylj-2-pyrrolidinone |
11/16/1994 | CN1026588C Novel 1-alkyl substituted benzimidazole derivatives |
11/16/1994 | CN1026586C Novel thiazolidinone derivatives, pharmaceutical compositions containing them and process for preparing same |
11/15/1994 | US5364943 Preparation of substituted piperidines |
11/15/1994 | US5364942 Sulphonylbenzyl-substituted imidazopyridines |
11/15/1994 | US5364938 Triazole antifungal agents |
11/15/1994 | US5364931 Phosphonate-containing pseudopeptides of the hydroxyethylamine and norstatin type |
11/15/1994 | US5364884 Arginine compounds as ocular hypotensive agents |
11/15/1994 | US5364883 Prostaglandins |
11/15/1994 | US5364882 Acyloenzyme a: cholesterol acyltransferase inhibitors, anticholesterol |
11/15/1994 | US5364880 Compound for treatment of cardiac arrhythmia, synthesis, and methods of use |
11/15/1994 | US5364879 Skin disorders, bactericides, fungicides, antiprotozoa agents, viricides and antiinflammatory agents |
11/15/1994 | US5364878 Use of substituted 3,4-dihydro-2H-benzopyrans as remedies for obstructive functional disorders of the lungs |
11/15/1994 | US5364877 Indole derivatives as 5-lipoxygenase inhibitors |
11/15/1994 | US5364868 Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
11/15/1994 | US5364866 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
11/15/1994 | US5364865 Phenoxy- and phenoxyalkyl-piperidines as antiviral agents |
11/15/1994 | US5364864 Enzyme inhibitors |
11/15/1994 | US5364862 Adenosine derivatives |
11/15/1994 | US5364860 Naphthyridine compounds which inhibit tyrosine kinase and their pharmaceutical compositions |
11/15/1994 | US5364859 Antiinflammatory agents, antiallergens, bronchodilators |
11/15/1994 | US5364858 Camptothecin analogs as potent inhibitors of topoisomerase I |
11/15/1994 | US5364857 Cerebral antiischaemic agents, chroman and fluorophenyl compound |
11/15/1994 | US5364856 Modification of serotonin function |
11/15/1994 | US5364855 Cardiovascular disorders or antiarrthmia agents |
11/15/1994 | US5364854 Nervous system and gastrointestinal disorders; antiemetic, anxiolytic, and analgesic agents; cognition activators; drug abuse |
11/15/1994 | US5364853 Treatment of disorders associated with vascular, respiratory, gastrointestinal tract, urinary bladder or uterus smooth muscle contraction |
11/15/1994 | US5364847 Inhibitors of sex steroid biosynthesis and methods for their production and use |
11/15/1994 | US5364846 N-cycloalkylaminoethane-1,1-bis (phosphonic acid) useful for the treatment of osteoporosis and degenerative joint disease |
11/15/1994 | US5364845 Glucosamine, chondroitin and manganese composition for the protection and repair of connective tissue |
11/15/1994 | US5364843 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
11/15/1994 | US5364839 Osteoinductive pharmaceutical formulations |
11/15/1994 | US5364794 With 2-6 glucose units, attachment of starch to carrier, exo-cleavage |
11/15/1994 | US5364757 Methods of supporting a diagnosis of systemic lupus erythematosus |
11/15/1994 | US5364652 Potato starch treated with heat and hydrochloric acid and hydrolyzed with amylase and glucoamylase; dietetics; fibers; foods |
11/15/1994 | US5364646 Oral pharmaceutical forms of pimobendan |
11/15/1994 | US5364644 Calcium or potassium glucarate |
11/15/1994 | US5364642 Ionized magnesium2+ concentrations in biological samples |
11/15/1994 | US5364636 Inhibitor of absorption of digestion product of food and drink |
11/15/1994 | US5364635 Mixing, drying and compaction with granulation to form tablets |
11/15/1994 | US5364631 Tocopherol-based pharmaceutical systems |
11/15/1994 | US5364630 Subsaturated nicotine transdermal therapeutic system |
11/15/1994 | US5364629 Device and method for enhanced administration of physostigmine |
11/15/1994 | US5364628 Pharmaceutical compositions |
11/15/1994 | US5364625 Dermatology |
11/15/1994 | US5364620 Controlled absorption diltiazem formulation for once daily administration |
11/15/1994 | US5364617 Chelator compositions comprising oxime compounds |
11/15/1994 | US5364616 Use of H-2 antagonists for treatment of gingivitis |
11/15/1994 | US5364615 Prophylaxis of pneumocystis carinii with aerosilized pentamidine |
11/15/1994 | US5364563 Powdered aqueous carotenoid dispersions |
11/15/1994 | CA1333067C Ring substituted isoquinolines |
11/15/1994 | CA1333053C Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
11/15/1994 | CA1333052C Apparatus for the controlled delivery of nicotine, process for the production thereof and the use thereof |
11/15/1994 | CA1333051C Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method |
11/14/1994 | CA2123243A1 Substituted mono- and bipyridylmethylpyridones |
11/13/1994 | CA2123267A1 Substituted indoles, process for their preparation and pharmaceutical compositions containing them |
11/13/1994 | CA2123261A1 Urethanes and ureas that induce cytokine production |
11/13/1994 | CA2123162A1 4-substituted benzopyran and related compounds |
11/12/1994 | CA2123163A1 Intermediates useful in the preparation of pyranyl cyanoguanidine derivatives and methods of preparing same |
11/12/1994 | CA2114668A1 Positively charged polyvinylidene fluoride membrane |
11/11/1994 | CA2122885A1 Process for the preparation of 2-{4-¬4-(4-chloro-1-pyrazolyl) butyl|-1-piperazinyl}pyrimidine (lesopitron) |
11/11/1994 | CA2122814A1 Method for treating acquired immune deficiency syndrome |
11/11/1994 | CA2121567A1 Substituted pyrroles |
11/10/1994 | WO1994025626A1 Dna profiles as an indicator of cellular redox potential and cancer risk |
11/10/1994 | WO1994025601A2 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
11/10/1994 | WO1994025588A2 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β) |
11/10/1994 | WO1994025582A1 Method of enhancing thrombolysis |
11/10/1994 | WO1994025573A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
11/10/1994 | WO1994025566A1 1-n-ethyl gentamicin derivatives, and the method for preparing thereof |
11/10/1994 | WO1994025479A1 Spirostanyl glycosidal crystalline monohydrate |
11/10/1994 | WO1994025477A2 Novel peptide nucleic acids |
11/10/1994 | WO1994025472A1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments |
11/10/1994 | WO1994025471A1 Phosphoramidates useful as antitumor agents |
11/10/1994 | WO1994025470A1 Benzo[f]quinoxalindione derivatives, their preparation and their use in drugs |
11/10/1994 | WO1994025469A1 Quinoxalindione derivatives, their preparation and their use in drugs |
11/10/1994 | WO1994025466A1 Water soluble derivatives of camptothecin and their use as antitumor agents |
11/10/1994 | WO1994025465A1 SUBSTITUTED METHYLENEDIOXY[3',4':6,7]INDOLIZINO-[1,2-b]QUINOLINONES |
11/10/1994 | WO1994025460A1 Risperidone pamoate |
11/10/1994 | WO1994025459A1 Heterocyclic derivatives |
11/10/1994 | WO1994025456A1 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
11/10/1994 | WO1994025454A1 Agent acting on the central nervous system, method for its preparation and pharmaceutical compositions containing such agent |